Mercer Global Advisors’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$407K Buy
1,785
+449
+34% +$114K ﹤0.01% 2690
2026
Q2
$356K Buy
1,336
+271
+25% +$63.3K ﹤0.01% 2625
2026
Q1
$244K Buy
1,065
+7
+0.7% +$1.57K ﹤0.01% 2648
2025
Q4
$226K Hold
1,058
– – ﹤0.01% 2465
2025
Q3
$210K Sell
1,058
-2,070
-66% -$386K ﹤0.01% 2359
2025
Q2
$540K Buy
+3,128
New +$510K ﹤0.01% 1532

Other funds holding ASND

Mercer Global Advisors's ASND Position: Q3 2026 in Review

Mercer Global Advisors increased its Ascendis Pharma (ASND) stake by 34% in Q3 2026, buying an estimated $114K and bringing the position to 1,785 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #2690.

Mercer Global Advisors first reported a position in ASND in Q2 2025 and has held it in 6 quarters since. The position peaked at $540K in Q2 2025. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Mercer Global Advisors held 1,785 shares of Ascendis Pharma worth $407K as of Q3 2026.
  • Mercer Global Advisors bought 449 Ascendis Pharma shares in Q3 2026, an estimated $114K.
  • Ascendis Pharma made up ﹤0.01% of Mercer Global Advisors's portfolio in Q3 2026, its #2690 holding.
  • Mercer Global Advisors first reported a position in Ascendis Pharma in Q2 2025 and has held it in 6 quarters since.
  • Mercer Global Advisors's Ascendis Pharma position peaked at $540K in Q2 2025.
  • 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.

Based on Mercer Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.